Patent ID: 11897888
Assignee: STINGINN, LLC
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. The compound of claim 1, selected from the group consisting of 2-chloro-N-[3-cyano-1-(2-phenoxyethyl)-1H-pyrrolo[2,3-b]quinoxalin-2-yl]benzamide, 2-chloro-N-[3-cyano-1-(2-methoxyethyl)-1H-pyrrolo[2,3-β]quinoxalin-2-yl]benzamide, 2-chloro-N-[3-cyano-1-(2-phenylethyl)-1H-pyrrolo[2,3-β]quinoxalin-2-yl]-5-methylbenzamide, 2-chloro-N-[3-cyano-1-(2-phenylethyl)-1H-pyrrolo[2,3-b]quinoxalin-2-yl]-3-fluorobenzamide, 2-chloro-N-[3-cyano-1-(2-phenylethyl)-1H-pyrrolo[2,3-b]quinoxalin-2-yl]-6-fluorobenzamide, 2-chloro-N-[3-cyano-1-[2-(3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]quinoxalin-2-yl}benzamide, 2,3-dichloro-N-[3-cyano-1-(2-phenylethyl)-1H-pyrrolo[2,3-b]quinoxalin-2-yl]benzamide and 2-chloro-N-[3-cyano-1-(2-phenylethyl)-1H-pyrrolo[2,3-β]quinoxalin-2-yl]-3-methylbenzamide, further comprising a pharmaceutically acceptable physiologically compatible excipient.